Search

Your search keyword '"Sbianchi, Giulia"' showing total 8 results
Start Over Author "Sbianchi, Giulia" Publication Year Range Last 3 years
8 results on '"Sbianchi, Giulia"'

1. Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWP

Author

Onida, Francesco, Sbianchi, Giulia, Radujkovic, Aleksandar, Sockel, Katja, Kröger, Nicolaus, Sierra, Jorge, Socié, Gerard, Cornelissen, Jan, Poiré, Xavier, Raida, Luděk, Bourhis, Jean Henri, Finke, Jürgen, Passweg, Jakob, Salmenniemi, Urpu, Schouten, Harry C., Beguin, Yves, Martin, Sonja, Deconinck, Eric, Ganser, Arnold, Zver, Samo, Lioure, Bruno, Rohini, Radia, Koster, Linda, Hayden, Patrick, Iacobelli, Simona, Robin, Marie, and Yakoub-Agha, Ibrahim

Published
2022
Full Text
View/download PDF

3. Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT

Author

Kröger, Nicolaus, Sbianchi, Giulia, Sirait, Tiarlan, Wolschke, Christine, Beelen, Dietrich, Passweg, Jakob, Robin, Marie, Vrhovac, Radovan, Helbig, Grzegorz, Sockel, Katja, Conneally, Eibhlin, Rubio, Marie Thérèse, Beguin, Yves, Finke, Jürgen, Bernasconi, Paolo, Morozova, Elena, Clausen, Johannes, von dem Borne, Peter, Schaap, Nicolaas, Schroyens, Wilfried, Patriarca, Francesca, Di Renzo, Nicola, Yeğin, Zeynep Arzu, Hayden, Patrick, McLornan, Donal, and Yakoub-Agha, Ibrahim

Published
2021
Full Text
View/download PDF

4. Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT

Author

Kröger, Nicolaus, Sbianchi, Giulia, Sirait, Tiarlan, Wolschke, Christine, Beelen, Dietrich, Passweg, Jakob, Robin, Marie, Vrhovac, Radovan, Helbig, Grzegorz, Sockel, Katja, Conneally, Eibhlin, Rubio, Marie Thérèse, Beguin, Yves, Finke, Jürgen, Bernasconi, Paolo, Morozova, Elena, Clausen, Johannes, von dem Borne, Peter, Schaap, Nicolaas, Schroyens, Wilfried, Patriarca, Francesca, Di Renzo, Nicola, Yeğin, Zeynep Arzu, Hayden, Patrick, McLornan, Donal, and Yakoub-Agha, Ibrahim

Abstract

JAK1/2 inhibitor ruxolitinib (RUX) is approved in patients with myelofibrosis but the impact of pretreatment with RUX on outcome after allogeneic hematopoietic stem cell transplantation (HSCT) remains to be determined. We evaluated the impact of RUX on outcome in 551 myelofibrosis patients who received HSCT without (n= 274) or with (n= 277) RUX pretreatment. The overall leukocyte engraftment on day 45 was 92% and significantly higher in RUX responsive patients than those who had no or lost response to RUX (94% vs. 85%, p= 0.05). The 1-year non-relapse mortality was 22% without significant difference between the arms. In a multivariate analysis (MVA) RUX pretreated patients with ongoing spleen response at transplant had a significantly lower risk of relapse (8.1% vs. 19.1%; p= 0.04)] and better 2-year event-free survival (68.9% vs. 53.7%; p= 0.02) in comparison to patients without RUX pretreatment. For overall survival the only significant factors were age > 58 years (p= 0.03) and HLA mismatch donor (p= 0.001). RUX prior to HSCT did not negatively impact outcome after transplantation and patients with ongoing spleen response at time of transplantation had best outcome.

Published
2024
Full Text
View/download PDF

5. Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM Study

Author

Waszczuk-Gajda, Anna, primary, Penack, Olaf, additional, Sbianchi, Giulia, additional, Koster, Linda, additional, Blaise, Didier, additional, Reményi, Péter, additional, Russell, Nigel, additional, Ljungman, Per, additional, Trneny, Marek, additional, Mayer, Jiri, additional, Iacobelli, Simona, additional, Kobbe, Guido, additional, Scheid, Christof, additional, Apperley, Jane, additional, Touzeau, Cyrille, additional, Lenhoff, Stig, additional, Jantunen, Esa, additional, Anagnostopoulos, Achilles, additional, Paris, Laura, additional, Browne, Paul, additional, Thieblemont, Catherine, additional, Schaap, Nicolaas, additional, Sierra, Jorge, additional, Yakoub-Agha, Ibrahim, additional, Garderet, Laurent, additional, Styczynski, Jan, additional, Schoemans, Helene, additional, Moiseev, Ivan, additional, Duarte, Rafael F., additional, Peric, Zinaida, additional, Montoto, Silvia, additional, van Biezen, Anja, additional, Mikulska, Malgorzata, additional, Aljurf, Mahmoud, additional, Ruutu, Tapani, additional, Kröger, Nicolaus, additional, Morris, Curly, additional, Koenecke, Christian, additional, Schoenland, Stefan, additional, and Basak, Grzegorz W., additional

Published
2022
Full Text
View/download PDF

6. Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors: A retrospective study by the chronic malignancies working party of the EBMT.

Author

Chalandon, Yves, Sbianchi, Giulia, Gras, Luuk, Koster, Linda, Apperley, Jane, Byrne, Jenny, Salmenniemi, Urpu, Sengeloev, Henrik, Aljurf, Mahmoud, Helbig, Grzegorz, Kinsella, Francesca, Choi, Goda, Reményi, Péter, Snowden, John A., Robin, Marie, Lenhoff, Stig, Mielke, Stephan, Passweg, Jakob, Broers, Annoek E. C., and Kröger, Nicolaus

Published
2023
Full Text
View/download PDF

7. IgD Subtype But Not IgM or Non-Secretory Is a Prognostic Marker for Poor Survival Following Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Results From the EBMT CALM (Collaboration to Collect Autologous Transplant Outcomes in Lymphomas and Myeloma) Study

Author

Lawless, Sarah, primary, Sbianchi, Giulia, additional, Morris, Curly, additional, Iacobelli, Simona, additional, Bosman, Paul, additional, Blaise, Didier, additional, Reményi, Péter, additional, Byrne, J.L., additional, Mayer, Jiri, additional, Apperley, Jane, additional, Lund, Johan, additional, Kobbe, Guido, additional, Schaap, Nicolaas, additional, Isaksson, Cecilia, additional, Lenhoff, Stig, additional, Basak, Grzegorz, additional, Touzeau, Cyrille, additional, Wilson, Keith M.O., additional, González Muñiz, Soledad, additional, Scheid, Christof, additional, Browne, Paul, additional, Anagnostopoulos, Achilles, additional, Rambaldi, Alessandro, additional, Jantunen, Esa, additional, Kröger, Nicolaus, additional, Schönland, Stefan, additional, Yakoub-Agha, Ibrahim, additional, and Garderet, Laurent, additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results